ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2015

Feb 19, 2015

SEC Form 3/A — Form 3/A

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-02-17

Reporting Person: CARE CAPITAL II LLC (10% Owner)
Reporting Person: CARE CAPITAL INVESTMENTS II LP (10% Owner)
Reporting Person: Care Capital Offshore Investments II LP (10% Owner)
Reporting Person: Care Capital III LLC (10% Owner)
Reporting Person: Care Capital Investments III L.P. (10% Owner)
Reporting Person: Care Capital Offshore Investments III LP (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$4.342	2024-08-28	Common Stock (9857)		Indirect

Footnotes

F1: These options are fully vested.

F2: The expiration date for the options was incorrectly reported on the reporting persons' original Form 3. The reporting persons have not repeated any other lines from the original Form 3 pursuant to General Instruction 8(b) of Form 3.

F3: This option was granted to Dr. Argeris Karabelas, a member of Care Capital II, LLC and Care Capital III, LLC (together, the "General Partners"). Under the partnership agreements for each of General Partners, Dr. Karabelas is deemed to hold the option for the benefit of the General Partners and may exercise the option solely upon the direction of the General Partners, which are entitled to the shares issued upon the exercise. The General Partners, Care Capital Investments II, LP, Care Capital Offshore Investments II, LP, Care Capital Investments III, LP and Care Capital Offshore Investments III, LP may be deemed indirect beneficial owners of the option. The reporting persons disclaim beneficial ownership of the option except to the extent of their pecuniary interest therein.